IN THE NEWS
May 7th, 2019
PneumoNIX Medical endorsed by Johns Hopkins Lung Cancer Screening Initiative (Cigarette Restitution Fund)
PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development Corporation of Maryland about their technology and its ability to increase access to lung cancer screening. The successful large-animal data which was acquired with grant funding has gathered interest from physicians and public health officials about its ability to reduce costs and complications during the lung cancer screening process. Additionally, the results have fast-tracked them for further grant funding.
PneumoNIX selected to present at 2019 Angel Capital Association Innovation Showcase
PneumoNIX Medical is 1 of 50 startups nationwide selected to present to the nations top angel investors. The showcase features the most promising startups from life science and technology companies.
March 15th, 2019
PneumoNIX attends ASPIRE investor readiness program through VentureWell
PneumoNIX was selected as 1 of 15 MedTech start-ups to attend VentureWell’s investor readiness program. The program ensures the companies have a solidified go-to-market plan with planned milestones and a comprehensive due diligence deal room package. Furthermore, PneumoNIX secured partnerships to help with product launch and market adoption.
February 1st, 2019
pneumonix awarded Maryland industrial partnerships program phase I grant
November 26th, 2018
pneumonix wins venturewell e-team phase II grant for preventing ptx
Meet PneumoNIX team at the VentureWell E-team workshop in Boston from Jan. 31st - Feb. 2nd
August 2nd, 2018
Pneumonix medical awarded the Cigarette Restitution Fund Grant by State of Maryland
June 12th, 2018
July 15th, 2018
Pneumonix awarded the Johns Hopkins tech acceleration fund grant
July 13th, 2018